AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Pharmaceutical Companies

657.063

-2.060-0.31%

Number of Gainers:8

Number of Losers:15

Number of Flat:20

PE:- -

High:668.731

Open:663.741

Low:652.831

Close:659.123

Volume:33.88M

Turnover:180.84M

Market Cap:93.67B

Float Cap:90.54B

Loading ...

Imricor Medical Systems, Inc-FDA Accepts Imricor Pma Manufacturing Module

THOMSON REUTERS

Prescient Therapeutics Hits Dose Optimization Review Milestone in Cancer Drug Study

MT Newswires Live

CSL Bulls Don't See Large Impact from U.S. Pricing Deals

Tissue Repair - Resumes Direct Distribution of Tr Pro+ in Australia and New Zealand

THOMSON REUTERS

Dimerix - Trading Halt Requested Pending Announcement on Non-Dilutive Funding Arrangements

THOMSON REUTERS

Here's Why We're Not Too Worried About AnteoTech's (ASX:ADO) Cash Burn Situation

Simply Wall St.

ASX Growth Companies With High Insider Ownership You Should Know

Simply Wall St.

3 ASX Stocks Estimated To Be Undervalued In September 2026

Simply Wall St.

PAR Technology Launches Platform to Connect Restaurant Guest Data

MT Newswires Live

Global Pharma Companies That Have Publicly Announced Trump Drug Pricing Agreements

Australia's Monash IVF at over Four-Month High on Upbeat FY27 Outlook

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigerfiesta.com/stock/BK7508/news?page=4"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK7508","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK7508\",,,,,undefined,":{"symbol":"BK7508","market":"AU","secType":"PLATE","nameCN":"Pharmaceutical Companies","latestPrice":657.06305,"timestamp":1789538399653,"preClose":659.12286,"halted":0,"volume":33876933,"delay":0,"changeRate":-0.003125,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Not Yet Opened","change":-2.059814,"latestTime":"09-16 16:00:00 AEST","open":663.74115,"high":668.7309,"low":652.8311,"amount":180844645,"amplitude":0.024123,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1789603200000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1789516800000,1789538400000]],"turnoverRate":0.001328,"increases":8,"decrements":16,"flats":19,"marketCap":93671629289.75,"floatMarketCap":90538125826.625},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK7508\",,,,,undefined,":{"symbol":"BK7508","high":668.7309,"amplitude":0.024123,"preClose":659.12286,"low":652.8311,"latestPrice":657.06305,"volume":33876933,"delay":0,"open":663.74115,"prevYearClose":644.3692,"prevWeekClose":634.95,"prevMonthClose":656.138,"prevQuarterClose":464.145,"fiveDayClose":655.041,"twentyDayClose":646.662,"sixtyDayClose":461.734,"secType":"PLATE","market":"AU","turnoverRate":0.001328,"marketCap":93671629289.75,"floatMarketCap":90538125826.625,"timestamp":1789538399653,"nameCN":"Pharmaceutical Companies"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK7508\",,,,undefined,":{"bkCode":"BK7508","up":8,"down":15,"flat":20},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK7508\",pageSize:20,pageCount:4,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2664784413","title":"Imricor Medical Systems, Inc-FDA Accepts Imricor Pma Manufacturing Module","url":"https://stock-news.laohu8.com/highlight/detail?id=2664784413","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664784413?lang=en_us&edition=fundamental","pubTime":"2026-09-03 06:21","pubTimestamp":1788387678,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nTUEBD40TZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7007","IMR.AU","BK7508","BK7503"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664999896","title":"Prescient Therapeutics Hits Dose Optimization Review Milestone in Cancer Drug Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2664999896","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664999896?lang=en_us&edition=fundamental","pubTime":"2026-09-02 13:38","pubTimestamp":1788327489,"startTime":"0","endTime":"0","summary":"Prescient Therapeutics  reached the pre-specified enrollment threshold for its first planned dose optimization committee review in a phase 2a study of its PTX-100 drug candidate in relapsed or refractory cutaneous T-cell lymphoma, according to a Wednesday filing with the Australian bourse.The company said 10 evaluable patients, or those who have completed four cycles of treatment, are now enrolled in each of the study's two dosing arms for 20 evaluable patients in total.The first dose optimization committee review remains on track for December, and enrollment in the study continues globally toward a full target of 40 evaluable patients.Cutaneous T-cell lymphoma is a type of immune system cancer where abnormal white blood cells migrate to and attack the skin.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LENZ","PTX.AU","BK7067","BK4139","BK4007","BK7508","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664918898","title":"CSL Bulls Don't See Large Impact from U.S. Pricing Deals","url":"https://stock-news.laohu8.com/highlight/detail?id=2664918898","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664918898?lang=en_us&edition=fundamental","pubTime":"2026-09-02 10:29","pubTimestamp":1788316140,"startTime":"0","endTime":"0","summary":"0229 GMT - CSL's bulls at UBS don't think the Australia-based pharmaceutical company will experience much of a direct financial impact from its U.S. pricing agreements. CSL has agreed to give Medicaid access to medicines at prices comparable to those in other developed economies, but the investment bank's analysts point out that the state-based program accounts for a relatively small part of its U.S. sales. On top of that, they don't see obligations around the pricing of future drug launches as onerous, given that CSL will be in control of settings and able to manage the impact in its best interests. UBS has a last-published buy rating on the stock and a target price of 181.00 Australian dollars. Shares are up 0.5% at A$173.12.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7501","CSL.AU","BK7511","BK7067","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664862357","title":"Tissue Repair - Resumes Direct Distribution of Tr Pro+ in Australia and New Zealand","url":"https://stock-news.laohu8.com/highlight/detail?id=2664862357","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664862357?lang=en_us&edition=fundamental","pubTime":"2026-09-02 07:58","pubTimestamp":1788307093,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260901:nFWN44T18J:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7067","TRP.AU","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664864668","title":"Dimerix - Trading Halt Requested Pending Announcement on Non-Dilutive Funding Arrangements","url":"https://stock-news.laohu8.com/highlight/detail?id=2664864668","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664864668?lang=en_us&edition=fundamental","pubTime":"2026-09-02 06:43","pubTimestamp":1788302639,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260901:nFWN44T15S:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7067","DXB.AU","BK7501","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664675118","title":"Here's Why We're Not Too Worried About AnteoTech's (ASX:ADO) Cash Burn Situation","url":"https://stock-news.laohu8.com/highlight/detail?id=2664675118","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664675118?lang=en_us&edition=fundamental","pubTime":"2026-09-02 05:26","pubTimestamp":1788297996,"startTime":"0","endTime":"0","summary":"Just because a business does not make any money, does not mean that the stock will go down. For example, although...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/materials/asx-ado/anteotech-shares/news/heres-why-were-not-too-worried-about-anteotechs-asxado-cash","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/materials/asx-ado/anteotech-shares/news/heres-why-were-not-too-worried-about-anteotechs-asxado-cash","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7501","ADO.AU","BK7036","BK7048","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664320861","title":"ASX Growth Companies With High Insider Ownership You Should Know","url":"https://stock-news.laohu8.com/highlight/detail?id=2664320861","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664320861?lang=en_us&edition=fundamental","pubTime":"2026-09-02 03:08","pubTimestamp":1788289704,"startTime":"0","endTime":"0","summary":"Amidst a backdrop of geopolitical tensions in the Middle East and fluctuating oil prices, the Australian market is experiencing volatility, with the S&P/ASX 200 expected to open lower following Wall Street's decline. In such uncertain times, identifying growth companies with high insider ownership can offer insights into potential resilience and confidence within those businesses.","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/2052000-choice1-main-header/1585186836557","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/2052000-choice1-main-header/1585186836557"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/materials/asx-ltr/liontown-shares/news/asx-growth-companies-with-high-insider-ownership-you-should","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/materials/asx-ltr/liontown-shares/news/asx-growth-companies-with-high-insider-ownership-you-should","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["SPL.AU","FRS.AU","XKO.AU","LTR.AU","STW.AU","AV1.AU","BK7067","QRE.AU","XAO.AU","BK7023","IIGF.AU","PDI.AU","QFN.AU","OZF.AU","AR1.AU","TLX","BK4139","VAP.AU","VAS.AU","BK7137","WZR.AU","IISV.AU","BEAR.AU","TTT.AU","XJO.AU","SLF.AU","OZR.AU","DACE.AU","EIGA.AU","EIQ.AU","BBOZ.AU","BK7508","BK7093","AWJ.AU","GIVE.AU","TLX.AU","BK7104","E200.AU","ZYAU.AU","BK7096","BK7501","GYG.AU","BK7036","IMLC.AU","BK7110","SKS.AU","BK7016","GEAR.AU","BK7504","IOZ.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664861352","title":"3 ASX Stocks Estimated To Be Undervalued In September 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2664861352","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664861352?lang=en_us&edition=fundamental","pubTime":"2026-09-02 03:05","pubTimestamp":1788289503,"startTime":"0","endTime":"0","summary":"As geopolitical tensions in the Middle East contribute to volatility in global markets, the Australian Stock Exchange (ASX) is feeling the impact with a cautious start, influenced by fluctuating oil prices and broader economic concerns. In such uncertain times, identifying undervalued stocks can offer potential opportunities for investors seeking resilience amidst market fluctuations.","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/7131000-choice1-main-header/1585186655666","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/7131000-choice1-main-header/1585186655666"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/diversified-financials/asx-pni/pinnacle-investment-management-group-shares/news/3-asx-stocks-estimated-to-be-undervalued-in-september-2026","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/diversified-financials/asx-pni/pinnacle-investment-management-group-shares/news/3-asx-stocks-estimated-to-be-undervalued-in-september-2026","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7062","STH.AU","BK7508","BK7061","LOV.AU","NXL.AU","NDO.AU","BK7126","GNP.AU","BK4526","ASX","MP1.AU","PNI.AU","ASX.AU","SPHQ","SLC.AU","SDV.AU","BK7055","BK7094","CAT.AU","BK7503","BK7015","BK7017","BK7016","BK4543","BK7128","BK7039","BK4585","BK7084","BK7120","BK7043","BMT.AU","BK4141","TEA.AU","PNV.AU","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664548468","title":"PAR Technology Launches Platform to Connect Restaurant Guest Data","url":"https://stock-news.laohu8.com/highlight/detail?id=2664548468","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664548468?lang=en_us&edition=fundamental","pubTime":"2026-09-01 21:17","pubTimestamp":1788268623,"startTime":"0","endTime":"0","summary":"PAR Technology  said Tuesday it has launched a new customer data platform to recognize restaurant guests from their first transaction and unify activity across ordering, payment and other channels.The Guest360 platform works alongside PAR Punchh to create unified guest profiles from in-store, digital and loyalty activity, PAR Technology said.The platform can use the profiles to create dynamic audiences that update automatically based on real spend, visit frequency, menu preference for personalized offers and loyalty milestones, it said.PAR Technology shares were 2% lower in Tuesday premarket activity.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7508","PAR.AU","PAR","BK4023","BK4209","QSR","BK4157","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664568448","title":"Global Pharma Companies That Have Publicly Announced Trump Drug Pricing Agreements","url":"https://stock-news.laohu8.com/highlight/detail?id=2664568448","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664568448?lang=en_us&edition=fundamental","pubTime":"2026-09-01 19:49","pubTimestamp":1788263354,"startTime":"0","endTime":"0","summary":"FACTBOX-Global pharma companies that have publicly announced Trump drug pricing agreementsSept 1 (Reuters)-U.S. President Donald Trump has struck drug-pricing deals with more than 20 pharmaceutical co","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260901:nL4N44T0TS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0859254822.USD","LU2430703095.HKD","TRUH","LU2112291526.USD","LU0234570918.USD","LU2746668974.SGD","LU2111349929.HKD","AMGN","LU0949170772.SGD","BK4566","FTXH","LU1267930490.SGD","LU1244550221.USD","LU0234572021.USD","LU2265009873.SGD","LU1868836914.USD","LU1506573853.SGD","IE00B3T34201.USD","SGXZ57979304.SGD","IE00B775H168.HKD","LU0237698245.USD","SGXZ80539844.SGD","LU1983299246.USD","LU2347655156.SGD","LU2125154778.USD","BK7501","LU2602419157.SGD","LU1979441026.SGD","LU2552382058.USD","LU0471298694.HKD","LU2505996509.AUD","LU0889566641.SGD","IE00BJJMRY28.SGD","LU1121112475.USD","LU0158827948.USD","BK4559","OZEM","LU2271345857.HKD","GILD","LU1585245621.USD","LU0174119429.USD","LU0320765992.SGD","LU2433249047.HKD","IE00BKPKM429.USD","LU1236620834.HKD","AGNG","LU1699723380.USD","IE00BGHQF631.EUR","LU1261432733.SGD","LU2264538146.SGD","REGN","IE00BSNM7G36.USD","WDNA","IE00B4JS1V06.HKD","LU0154236417.USD","THNR","LU2168564149.EUR","TBXU","LU1057294990.SGD","LU0072461881.USD","SG9999014880.SGD","LU1244550494.USD","LU1244550577.SGD","LU1941712348.USD","BK4532","LU0256863811.USD","LU1670627923.USD","LU1551013425.SGD","LU0109391861.USD","LU1989771016.USD","LU0354030438.USD","LU2430703251.USD","LU2237443895.HKD","LU0069063385.USD","LU2362541513.USD","LU0985320562.USD","NVS","LU2417539215.USD","LU0310800379.SGD","NVO","LU0345769128.USD","LU1923622614.USD","LU2360032135.SGD","LU1670710661.SGD","LU0965508806.USD","LU2491050154.USD","LU2129689514.USD","LU1430594728.SGD","BK4550","LLYZ","LU1116320901.HKD","LU1712237335.SGD","LU0980610538.SGD","LU2462157665.USD","GSK","LU0553294199.USD","LU0006306889.USD","LU1196500208.SGD","SG9999001440.SGD","BMED","LU1623119135.USD","JNJ","LU0306806265.USD","SGXZ31699556.SGD","LU2106854487.HKD","04332","LU1228905037.USD","LU0353189680.USD","LU0109394709.USD","LU0942090050.USD","LU1037948897.HKD","LU1323610961.USD","PBE","LU2468319806.SGD","SG9999013999.USD","LU1059921491.USD","LU0211327993.USD","IE0034235303.USD","LU0057025933.USD","LU2168564495.EUR","LU0820561909.HKD","LU2552382132.HKD","LU2125909247.SGD","IBBQ","SG9999015978.USD","IE000MB6IJN5.SGD","LU0124676726.USD","LU0868494708.USD","LU2023250504.SGD","LU1291159041.SGD","IE00B42XCP33.USD","BK4534","LLY","AZN","LU1629891620.HKD","LU1974910355.USD","ABBV","LU0061475181.USD","LU0385154629.USD","MRK","LU1674673428.USD","GSK.UK","LU1145028129.USD","LU2087621335.USD","LU1989772840.SGD","IHE","LU2361044949.HKD","LU0289961442.SGD","IE00BK4W5L77.USD","IE00BZ1G4Q59.USD","LU2237443978.SGD","IE0002270589.USD","LU1280957306.USD","LU1868836591.USD","LU0964807845.USD","BK4504","LU0868494617.USD","LU1093756168.USD","LU2125909593.SGD","CANC","LU1093756325.SGD","LU1670710588.SGD","IE00BFTCPJ56.SGD","LU2087625088.SGD","LU0882574139.USD","SG9999014542.SGD","LU0354030511.USD","LU2357627491.SGD","LU1066051225.USD","LU1037948541.HKD","LU0211328371.USD","LU1074936037.SGD","LU1267930573.SGD","LU0289739343.SGD","LU0395794307.EUR","LU2133065610.SGD","LU1883839398.USD","LU1720051017.SGD","LU2750360641.GBP","LU2213496289.HKD","LU1116320737.USD","IE00BBT3K403.USD","VHT","LU2456880835.USD","LU1066051498.USD","LU2023250330.USD","LU0208291251.USD","LU2487616109.SGD","LU0477156953.USD","NVOX","SG9999001176.SGD","LU2462591350.SGD","LLII","LU0861579265.USD","LU0097036916.USD","LU2242652126.USD","IE00B4R5TH58.HKD","BIB","LU0708994859.HKD","RXL","LU0426417589.USD","LU0795875086.SGD","LU0882574055.USD","LU0912757837.SGD","LU0203347892.USD","LU0787776722.HKD","LU0267386448.USD","IE00BN29S564.USD","SG9999014567.USD","GLAM","IE00BKVL7J92.USD","MEDX","LU0820561818.USD","LU2471134879.HKD","NVOC","LU1043141123.HKD","LU0098860793.USD","ONC","LU1929549753.HKD","LU1778281490.HKD","IBB","LU2028103732.USD","LU2491049909.HKD","SG9999014914.USD","BK4516","LU1162221912.USD","IE00BFXG1179.USD","LU1221951046.USD","LU0070217475.USD","IE00BJJMRZ35.SGD","IE0002141913.USD","LU0456855351.SGD","LU0466842654.USD","BK7508","FHLC","LU2089283258.USD","LU2896262040.SGD","LU1670628061.USD","IE000F7OJYX1.SGD","LU0965509283.SGD","LU0738911758.USD","LU1496350502.SGD","LU2168563687.JPY","LU0792757196.USD","LU0320765489.SGD","LU0820562030.AUD","SG9999002224.SGD","IE00BLSP4452.SGD","LU2361045086.USD","IE00B1BXHZ80.USD","LU0661504455.SGD","LU1935042991.SGD","AZNH","LU0689472784.USD","LU0210536198.USD","LU1003077747.HKD","LU0306807586.USD","LU0965509010.AUD","SG9999015986.USD","ELIS","GB00BDT5M118.USD","LU1267930813.SGD","SG9999014906.USD","LU0130102774.USD","LU1934455863.HKD","LU0323591593.USD","LU1691799644.USD","LLYX","LU0471298777.SGD","LU1571399168.USD","LU0985481810.HKD","IE00BN8TJ469.HKD","LU0640476718.USD","IE00BWXC8680.SGD","BK4599","LU1035775433.USD","LU0133085943.USD","LU0128525929.USD","LU2357305700.SGD","BK0239","BK7511","LU0965509101.SGD","LU2089984988.USD","LU2237443382.USD","SG9999001176.USD","LU1551013342.USD","LU1732800096.USD","GDOC","LU1221951129.SGD","LU1674673691.USD","LU2237438978.USD","LU0417517546.SGD","LU0511384066.AUD","LU0545039389.USD","LU1670711123.USD","XLV","BK4592","LU2089284900.SGD","LU0029864427.USD","IE00B3PB1722.GBP","LU2430703178.SGD","SG9999003800.SGD","LU0316494557.USD","LU0320765646.SGD","LU2362541273.HKD","SG9999011175.SGD","BBIO","LU1066051811.HKD","BK4581","LU2471134796.USD","IE00BVYPNW00.USD","SG9999014559.SGD","LU1236620750.USD","LU2023250843.SGD","LU1839511570.USD","LU1064131342.USD","LU0345770308.USD","IE00B19Z3B42.SGD","IE00B19Z3581.USD","LU0994945656.USD","PFE","LU0211331839.USD","LU0726765562.USD","LU1732799900.SGD","LU0225771236.USD","LU1201861249.SGD","LU0094547139.USD","LU1066053197.SGD","LU2362540622.SGD","LU1868837136.USD","LU2403377893.USD","LU0114720955.EUR","LU0079474960.USD","SG9999015952.SGD","SG9999014898.SGD","LU0203201768.USD","SG9999015358.SGD","LU2237443622.USD","LU0320765059.SGD","BBH","IE000WAW04H5.SGD","IE00BDGV0183.EUR","IE00BFSS7M15.SGD","SGXZ99366536.SGD","LU0266013472.USD","LU1228905540.USD","IYH","IE00B7KXQ091.USD","LU2491050071.SGD","LU2471134952.CNY","LU0289739699.SGD","HRTS","LU2360106947.USD","LU2461242641.AUD","LU2168564065.EUR","IE00BJT1NW94.SGD","IE000BZT7R73.USD","CSL.AU","LU1127390331.HKD","LU0683600562.USD","LU2746668461.USD","IXJ","IE0004445239.USD","BK4585","LU1868837300.USD","LU2063271972.USD","LU0648001328.SGD","LU0198837287.USD","SG9999018865.SGD","IE00B7SZLL34.SGD","LU2023251221.USD","LU2347655073.USD","GSKH","LU2129689605.HKD","IE0005OL40V9.USD","MHIP","SG9999014575.USD","LU1035773651.USD","LU1496350171.SGD","LU1829250122.USD","LU1917777945.USD","LU1941712264.USD","LU2750360997.AUD","PJP","BMY","LU1718418525.SGD","LU0823416689.USD","BK4568","LU1069347547.HKD","LU2237443549.SGD","IE000M9KFDE8.USD","BK4578","LU0238689110.USD","LU2237443465.HKD","LU2592432038.USD","LU1267930730.SGD","LU0170899867.USD","LU0053666078.USD","ILDR","LU1989772923.USD","LU0310799852.SGD","LU2108987350.USD","IE0000B7K699.USD","LU0943347566.SGD","LU0345769631.USD","IE0001KFT4U8.USD","LU1032955483.USD","LU0672654240.SGD","IE00BLSP4239.USD","LU1720051108.HKD","LU1023059063.AUD","LU0130517989.USD","LU1548497426.USD","LU0122379950.USD","LU0432979614.USD","LU1934455277.USD","LU0265550359.USD","LU2324357040.USD","LU1069344957.HKD","BK4533","LU0225283273.USD","LU0426412945.USD","LU1366192091.USD","LU2168564222.USD","LU1894683348.USD","IE00BJJMRX11.SGD","CURE","ELIL","LU0545562505.USD","TMED","SGXZ81514606.USD","LU0823434583.USD","LU1061106388.HKD","LU2505996681.GBP","LU0256863902.USD","BK4588","LU0070302665.USD","BK4007","PPH","MEDI","JDOC","LU0158827781.USD","LU0353189763.USD","IE00BKDWB100.SGD","BK4583","LU0321505439.SGD","SG9999002232.USD","SG9999015945.SGD","06160","SG9999015341.SGD","LU2236285917.USD","688235","LU1914381329.SGD","LU0096364046.USD","IE000SO60NU8.SGD","IE00B2B36J28.USD","PAWZ","LU2211815571.USD","LU0106261372.USD","BK4505","LU0265550946.USD","SGXZ51526630.SGD","LU2552382215.SGD","LU0689626769.HKD","BK7067","LU0210528500.USD","SG9999017495.SGD","LU1894683264.USD","LU2129689431.USD","LU1032466523.USD","IE00BFSS8Q28.SGD","LU1670711040.USD","LU2596442595.SGD","LU0162691827.USD","LU1232071149.USD","LU0203345920.USD","SG9999018857.SGD","IE00BK4W5M84.HKD","LU0889565916.HKD","LU2125154935.USD","IE0009355771.USD","LU1988902786.USD","LU1934455194.USD","LU0708995401.HKD","LU1868836757.USD","IE00BVYPNV92.GBP","LU2756315318.SGD","LU0795875169.SGD","BK4139","LU1804176565.USD","IE00BJLML261.HKD","LU0058720904.USD","LU0321505868.SGD","LU0203202063.USD","LU0823434740.USD","LU0786609619.USD","LU0472753341.HKD","NVOH","LU2361044865.SGD","LU2471134523.USD","LU2756315664.SGD","LU0225284248.USD","IE0004445015.USD","IE00B1XK9C88.USD","LU1814569148.SGD","LU2242646821.SGD","LU1043141396.HKD","LU0345770993.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664833759","title":"Australia's Monash IVF at over Four-Month High on Upbeat FY27 Outlook","url":"https://stock-news.laohu8.com/highlight/detail?id=2664833759","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664833759?lang=en_us&edition=fundamental","pubTime":"2026-09-01 13:59","pubTimestamp":1788242381,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's Monash IVF at over four-month high on upbeat FY27 outlook** Shares of Australia's Monash IVF GroupMVF.AXadvance as much as 12.3% to A$0.792, hitting their highest level since April 13** Stock extends gains after the fertility services provideroutlinesan upbeat FY27 outlook and declares a final dividend** Co says it expects FY27 performance to strengthen on market share gains, increased medical capacity and productivity initiatives** Adds, it plans to cut FY27 capital expenditure by about 50%** Co resumes dividends and declares a final dividend of 1.3 AU cents per share** Free cash flow improves to A$12.9 million from negative A$4.5 million a year earlier** YTD, stock up 4.8%","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260901:nL4N44T0FF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MVF.AU","BK7508","BK7113"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":4,"totalSize":71,"code":"91000000","status":"200"}]}}